Abiopharma

Mandatory Cash Dividend/ Distribution:

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Withdraw - Cash Dividend/ Distribution :: Mandatory

Withdraw - Notice Of Record Date

Withdraw - Cash Dividend/ Distribution :: Mandatory

Withdraw - Cash Dividend/ Distribution :: Mandatory

Mandatory Cash Dividend/ Distribution:

Withdraw - Cash Dividend/ Distribution :: Mandatory

Withdraw - Notice Of Record Date

General Announcement: ANNOUNCEMENT ON THE EVALUATION REPORT ON THE 2024 ACTION PLAN AND ON THE 2025 ACTION PLAN

FDA approve TOLTERODINE TARTRATE

FDA approve CLORAZEPATE DIPOTASSIUM

FDA approve CLORAZEPATE DIPOTASSIUM

FDA approve CEFAZOLIN SODIUM

FDA approve MEROPENEM